Brainstorm Cell Therapeutics Inc. (BCLI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.32M | -740K | -1.1M | -3.5M | -1.63M | -1.05M | -3.3M | -1.68M | -3.06M | -3.29M | -6.41M | -6.78M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | -957.73% | - | - |
| Operating CF Growth % | 19.07% | 29.39% | 66.6% | -108.08% | 46.75% | 68.1% | 48.53% | 75.17% | 23.16% | 29.32% | -32.14% | -10.5% |
| Net Income | -2.13M | -2.43M | -2.11M | -2.9M | -2.86M | -2.97M | -2.71M | -2.54M | -3.4M | -5.58M | -1.23M | -5.33M |
| Depreciation & Amortization | 37K | 48K | 48K | 51K | 52K | 53K | 59K | 64K | 64K | 66K | 65K | 67K |
| Stock-Based Compensation | 133K | 143K | 157K | 503K | 717K | 208K | 178K | 194K | 170K | 0 | 548K | 988K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 0 | 0 | 0 | -179K | -282K | -394K | -411K | -3K | -2.39M | -4.76M | 0 |
| Working Capital Changes | 637K | 1.5M | 799K | -1.15M | 643K | 1.95M | -434K | 1.01M | 107K | 4.62M | -1.03M | -2.5M |
| Change in Receivables | 109K | 224K | 188K | -5K | -490K | -2K | 149K | 133K | 121K | -479K | 345K | 238K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 250K | 647K | 423K | -800K | 717K | 1.48M | -737K | 650K | -264K | -972K | -1.26M | -2.61M |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 12K | 0 | 0 | 0 | 196K | -12K | 4K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.68M | 0 | 0 | -18K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 12K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.68M | 0 | 0 | 0 | 4K |
| Cash from Financing | 1.25M | 780K | 313K | 2.7M | 3.09M | 1.06M | 0 | 4.37M | 2.54M | 3.35M | 7.1M | 5.3M |
| Debt Issued (Net) | 280K | 781K | 0 | -1.1M | 900K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 970K | -1K | 313K | 3.35M | 685K | 1.06M | 0 | 4.37M | 2.54M | 3.35M | 7.1M | 5.3M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 450K | 1.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -70K | 40K | -789K | -801K | 1.46M | 19K | -3.3M | 2.69M | -524K | 78K | 676K | -1.48M |
| Free Cash Flow | -1.32M | -740K | -1.1M | -3.5M | -1.63M | -1.05M | -3.3M | -1.68M | -3.06M | -3.29M | -6.43M | -6.78M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | -957.73% | - | - |
| FCF Growth % | 19.07% | 29.39% | 66.6% | -108.08% | 46.75% | 68.1% | 48.67% | 75.17% | 23.16% | 29.32% | -32.49% | -10.16% |
| FCF per Share | -0.12 | -0.08 | -0.10 | -0.41 | -0.26 | -0.18 | -0.62 | -0.35 | -0.71 | -0.98 | -2.18 | -2.56 |
| FCF Conversion (FCF/Net Income) | 0.62x | 0.30x | 0.52x | 1.21x | 0.57x | 0.35x | 1.22x | 0.66x | 0.90x | 0.59x | 5.23x | 1.27x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |